Autopsy report · NCT04323631

Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death

“Trial not started due to accumulating evidence against HCQ for COVID”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Early Phase 1

Sponsor

Rambam Health Care Campus

Sponsor type

University, hospital or other

Conditions

COVID-19

Interventions

Hydroxychloroquine; The control group will not receive hydroxychloroquine

Participants

0

Trials that died the same way

• Use of a Rapid Diagnostic Test for Antibiotic De-escalation in Severe Community Acquired Pneumonia
  “COVID pandemic precluded trial initiation. No longer clinical equipoise” (71% match in meaning)
• PERSEUS-PS Randomized Controlled Trial
  “The trial prematurely terminated as a result of the COVID-19 pandemic.” (68% match in meaning)
• Platelet Transfusion in Sepsis Trial
  “COVID-19 trials gained priority” (67% match in meaning)
• Optimal Endoscopic Suturing Pattern for Esophageal Stent Fixation
  “Accrual difficulties: This trial was initiated prior to COVID-19 and interrupted by the pandemic for a significant length of time.” (66% match in meaning)
• Pedicle Osteotomy for Stenosis Trial
  “In light of the ongoing COVID-19 pandemic and its impact on clinical trials” (64% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.